BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Weingarden AR, Rubin SJS, Gubatan J. Immune checkpoint inhibitor-mediated colitis in gastrointestinal malignancies and inflammatory bowel disease. World J Gastrointest Oncol 2021; 13(8): 772-798 [PMID: 34457186 DOI: 10.4251/wjgo.v13.i8.772]
URL: https://www.wjgnet.com/2307-8960/full/v13/i8/772.htm
Number Citing Articles
1
Tuan Tran, Nguyen Giang Tien Tran, Vincent Ho. Checkpoint Inhibitors and the GutJournal of Clinical Medicine 2022; 11(3): 824 doi: 10.3390/jcm11030824
2
Ngozi Y. Enwerem, Eugene F. Yen. The colitis may be microscopic, but the diarrhea is not: update on the treatment of microscopic colitis and immune checkpoint inhibitor colitisCurrent Opinion in Gastroenterology 2024; 40(1): 50 doi: 10.1097/MOG.0000000000000986
3
Meher Afroz, Md. Shimul Bhuia, Md. Anisur Rahman, Rubel Hasan, Tawhida Islam, Md. Rakibul Islam, Raihan Chowdhury, Md. Ali Khan, Davi Antas e Silva, Henrique Douglas Melo Coutinho, Muhammad Torequl Islam. Anti-diarrheal effect of piperine possibly through the interaction with inflammation inducing enzymes: In vivo and in silico studiesEuropean Journal of Pharmacology 2024; 965: 176289 doi: 10.1016/j.ejphar.2023.176289
4
Aaron Lerner, Carina Benzvi. Checkpoint Inhibitors and Induction of Celiac Disease-like ConditionBiomedicines 2022; 10(3): 609 doi: 10.3390/biomedicines10030609
5
Simon-Johannes Lott, Michael Meiborg. Colitis ulcerosa-assoziiert oder hereditäre Genese?Gastro-News 2023; 10(1): 6 doi: 10.1007/s15036-022-3181-z
6
Seong Ran Jeon. The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel DiseasesThe Korean Journal of Gastroenterology 2023; 81(3): 142 doi: 10.4166/kjg.2023.025
7
Sara Kiparizoska, Megan E. Murphy, Mark C. Mattar. Check this out: treatment paradigms in immune-checkpoint inhibitor colitisCurrent Opinion in Gastroenterology 2023; 39(1): 43 doi: 10.1097/MOG.0000000000000892
8
Samantha Sharma, Naresh Singh, Anita Ahmed Turk, Isabella Wan, Akshay Guttikonda, Julia Lily Dong, Xinna Zhang, Mateusz Opyrchal. Molecular insights into clinical trials for immune checkpoint inhibitors in colorectal cancer: Unravelling challenges and future directionsWorld Journal of Gastroenterology 2024; 30(13): 1815-1835 doi: 10.3748/wjg.v30.i13.1815
9
Sigrun Grimsdottir, Mohamed Attauabi, Emilie Kristine Dahl, Johan Burisch, Jakob Benedict Seidelin. Systematic Review with Meta-analysis: The Impact of Cancer Treatments on the Disease Activity of Inflammatory Bowel DiseasesJournal of Crohn's and Colitis 2023; 17(7): 1139 doi: 10.1093/ecco-jcc/jjad010
10
Alexander R. Moschen, Yossi Sammy, Zoe Marjenberg, Amy B. Heptinstall, Nick Pooley, Agnieszka M. Marczewska. The Underestimated and Overlooked Burden of Diarrhea and Constipation in Cancer PatientsCurrent Oncology Reports 2022; 24(7): 861 doi: 10.1007/s11912-022-01267-3
11
Wenyi Li, Zhaokun Wu, Weidong Meng, Chaoting Zhang, Mingzhen Cheng, Yuehong Chen, Yini Zou, Kejun Li, Simin Lin, Wenjun Xiong, Ying Wang, Yixiong Lin, Wenhui Ma, Weijie Zhou. Blockade of IL-6 inhibits tumor immune evasion and improves anti–PD-1 immunotherapyCytokine 2022; 158: 155976 doi: 10.1016/j.cyto.2022.155976
12
Tsvetelina Velikova, Boris Krastev, Milena Gulinac, Miroslav Zashev, Vasko Graklanov, Milena Peruhova. New strategies in the diagnosis and treatment of immune-checkpoint inhibitor-mediated colitisWorld Journal of Clinical Cases 2024; 12(6): 1050-1062 doi: 10.12998/wjcc.v12.i6.1050